Arokiaswamy Velumani (born April 1959) is an Indian scientist and entrepreneur. He is the founder, chairman and managing director of Thyrocare Technologies Ltd. a chain of diagnostic and preventive care laboratories headquartered in Navi Mumbai. He is the founder and managing director of Nueclear Healthcare Limited, a radiology diagnostics company affiliated to Thyrocare.
After graduating in 1978, Velumani began with a job in 1979 at Gemini Capsules, a small pharmaceutical company in Coimbatore, Tamil Nadu as a shift chemist. After three years, the company was shut down. He then worked at Bhabha Atomic Research Centre (BARC) first as a laboratory assistant, staying for 14 years. During this time he pursued his Master’s and Doctor’s degree and rose to the rank of scientist. He later was posted at the Radiation Medicine Centre (RMC), a BARC department at Tata Memorial Hospital in Parel, Mumbai, Maharashtra.
Velumani decided to set up his own thyroid testing laboratory, Thyrocare, in 1996. He introduced a franchisee model in his diagnostic laboratory and offered affordable testing services. Thyrocare expanded from testing for thyroid disorders to preventive medical checkups and other diagnostic blood tests.
Under his leadership Thyrocare became the largest thyroid testing laboratory, with a network of more than 1000 outlets across India, Nepal, Bangladesh and the Middle East. In April 2016, Thyrocare conducted its Initial Public Offer (IPO) release, achieving over-subscription of 72.86 times.
Velumani is also the founder and managing director of Nueclear Healthcare Ltd. (NHL) a radiology diagnostics company with its main branch at Navi Mumbai, Maharashtra. This project offers cancer-related imaging services at half the cost of other providers.